| Literature DB >> 33069884 |
Rachel Sagar1, Graça Almeida-Porada2, Karin Blakemore3, Jerry K Y Chan4, Mahesh Choolani5, Cecilia Götherström6, Agnes Jaulent7, Tippi C MacKenzie8, Citra Mattar5, Christopher D Porada2, William H Peranteau9, Holm Schneider10, Steven W Shaw11, Simon N Waddington12, Magnus Westgren6, Anna L David13.
Abstract
Keywords: In utero stem cell transplantation; adverse event; clinical trial; fetal; fetal therapy; maternal; safety
Year: 2020 PMID: 33069884 PMCID: PMC7647692 DOI: 10.1016/j.ymthe.2020.10.012
Source DB: PubMed Journal: Mol Ther ISSN: 1525-0016 Impact factor: 11.454